Evidence map›Paper›PMID 40345367›Full record

ArticleContraception2025

One-year continuation of the etonogestrel contraceptive implant initiated with oral emergency contraception.

Lori M Gawron, Corinne D Sexsmith, Gentry Carter, Jennifer E Kaiser, Alexandra Woodcock, David K Turok

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Contraception, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Lori M GawronASCENT Center Department of Obstetrics and Gynecology, University of Utah, Salt Lake City, UT, United States. Electronic address: lori.gawron@hsc.utah.edu.
Corinne D SexsmithASCENT Center Department of Obstetrics and Gynecology, University of Utah, Salt Lake City, UT, United States.
Gentry CarterASCENT Center Department of Obstetrics and Gynecology, University of Utah, Salt Lake City, UT, United States.
Jennifer E KaiserASCENT Center Department of Obstetrics and Gynecology, University of Utah, Salt Lake City, UT, United States.
Alexandra WoodcockASCENT Center Department of Obstetrics and Gynecology, University of Utah, Salt Lake City, UT, United States.
David K TurokASCENT Center Department of Obstetrics and Gynecology, University of Utah, Salt Lake City, UT, United States.

Funding

Utah Center for Clinical and Translational ScienceUL1TR002538 · NCATS · UNIVERSITY OF UTAH · PI HESS, RACHEL, MAJERSIK, JENNIFER JUHL · 2018 to 2022
$26.0M
CTSA UM1 Program at University of UtahUM1TR004409 · NCATS · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI RACHEL HESS, Jennifer Juhl Majersik · 2023 to 2026
$21.9M
University of Utah Center for Clinical and Translational ScienceUL1TR001067 · NCATS · UNIVERSITY OF UTAH · PI DERE, WILLARD H., HESS, RACHEL · 2013 to 2017
$19.8M
Midcareer Investigator Award in Patient-Oriented Research K24K24HD087436 · NICHD · UNIVERSITY OF UTAH · PI TUROK, DAVID · 2017 to 2021
$942k
NCATS NIH HHS UL1 TR001067NCATS NIH HHS UL1 TR002538NCATS NIH HHS UM1 TR004409NICHD NIH HHS K24 HD087436
6 · The paper itself

Abstract

objectivesTo report the 1-year continuation rate of etonogestrel (ENG) implant users who initiated the method with same-day oral levonorgestrel emergency contraception (EC). STUDY

designEC clients age 18-35 years at four Utah family planning clinics between February 2021 and April 2023 initiated an ENG implant and completed follow-up surveys through 12-months.

resultsAt 12 months, we accounted for 132 (82.5%) of 160 participants: 79 (59.8%) still used their implant and 53 (40.2%) discontinued. A higher proportion of privately-insured participants discontinued (42% vs. 24%, p = 0.04).

conclusionsNearly 60% of participants who chose guideline-supported ENG implant placement at an EC clinical visit continued use at 1 year.

Indexed as

Contraception, PostcoitalContraceptive Agents, FemaleDesogestrelAdolescentAdultDrug ImplantsFemaleHumansLevonorgestrelUtahYoung AdultContraceptive Agents, FemaleDesogestrelDrug ImplantsetonogestrelLevonorgestrelContinuationEmergency contraceptionEtonogestrel implantLevonorgestrel

Identifiers

PMID40345367
PMCPMC12543269

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.